Xponance Inc. Has $1.13 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Xponance Inc. lowered its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 14.6% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 31,843 shares of the medical instruments supplier’s stock after selling 5,449 shares during the period. Xponance Inc.’s holdings in DENTSPLY SIRONA were worth $1,133,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in XRAY. Robeco Institutional Asset Management B.V. increased its holdings in DENTSPLY SIRONA by 487.3% in the third quarter. Robeco Institutional Asset Management B.V. now owns 838,117 shares of the medical instruments supplier’s stock worth $28,630,000 after buying an additional 695,419 shares during the last quarter. Invesco Ltd. boosted its position in shares of DENTSPLY SIRONA by 9.0% in the third quarter. Invesco Ltd. now owns 5,160,394 shares of the medical instruments supplier’s stock valued at $176,279,000 after acquiring an additional 428,229 shares during the period. Vanguard Group Inc. boosted its position in shares of DENTSPLY SIRONA by 1.5% in the third quarter. Vanguard Group Inc. now owns 25,250,443 shares of the medical instruments supplier’s stock valued at $862,555,000 after acquiring an additional 369,213 shares during the period. Raymond James & Associates boosted its position in shares of DENTSPLY SIRONA by 29.8% in the fourth quarter. Raymond James & Associates now owns 1,021,226 shares of the medical instruments supplier’s stock valued at $36,345,000 after acquiring an additional 234,322 shares during the period. Finally, Sasco Capital Inc. CT boosted its position in shares of DENTSPLY SIRONA by 32.4% in the third quarter. Sasco Capital Inc. CT now owns 839,250 shares of the medical instruments supplier’s stock valued at $28,669,000 after acquiring an additional 205,440 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on XRAY shares. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, January 19th. Barrington Research restated an “outperform” rating and issued a $41.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, April 18th. Piper Sandler upped their target price on DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a research note on Friday, January 12th. Needham & Company LLC restated a “buy” rating and issued a $42.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, February 29th. Finally, Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $39.50.

DENTSPLY SIRONA Stock Up 0.2 %

Shares of NASDAQ:XRAY opened at $30.92 on Thursday. DENTSPLY SIRONA Inc. has a twelve month low of $26.27 and a twelve month high of $43.24. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.95 and a current ratio of 1.38. The business has a fifty day moving average of $32.70 and a 200-day moving average of $32.81.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.01. The company had revenue of $1.01 billion during the quarter, compared to analyst estimates of $972.61 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same period last year, the company posted $0.46 earnings per share. Analysts forecast that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were issued a $0.16 dividend. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 annualized dividend and a yield of 2.07%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -103.22%.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.